Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBER Review “Paradigm Shift” Credited With Improved Cycle/Review Stats

This article was originally published in The Gray Sheet

Executive Summary

The Center for Biologics Evaluation & Research is working to identify problems with premarket applications earlier so they can be resolved in the first cycle of review, according to Robert Yetter, CBER associate director for review management

You may also be interested in...



Device Review Templates Are Milestones On Road To “Critical Path” – CBER

The Center for Biologics Evaluation & Research is flagging areas of the device review process that can be clarified through "templates" to guide staff and sponsors

Device Review Templates Are Milestones On Road To “Critical Path” – CBER

The Center for Biologics Evaluation & Research is flagging areas of the device review process that can be clarified through "templates" to guide staff and sponsors

CBER Should Retain Jurisdiction of Assigned Device Reviews – HHS Report

Improved device review times, including speedy handling of West Nile Virus diagnostics, convinced HHS that the Center for Biologics Evaluation & Research should retain jurisdiction over blood and tissue-related devices already assigned to the center

Related Content

UsernamePublicRestriction

Register

SC143420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel